Selected article for: "mitigation suppression and population level"

Author: Joshua S Weitz; Stephen J Beckett; Ashley R Coenen; David Demory; Marian Dominguez-Mirazo; Jonathan Dushoff; Chung-Yin Leung; Guanlin Li; Andreea Magalie; Sang Woo Park; Rogelio Rodriguez-Gonzalez; Shashwat Shivam; Conan Zhao
Title: Intervention Serology and Interaction Substitution: Modeling the Role of 'Shield Immunity' in Reducing COVID-19 Epidemic Spread
  • Document date: 2020_4_3
  • ID: drj3al9t_12
    Snippet: Serology testing is needed now, at scale, for many reasons. Here, we have shown a rationale for serology testing as a means to facilitate interventions beyond those of mitigation and suppression. Identifying and deploying recovered individuals could represent more than just a metric of the state of the COVID-19 epidemic, e.g., to better measure prevalence and the 'denominator', but an opportunity to slow transmission by developing population-leve.....
    Document: Serology testing is needed now, at scale, for many reasons. Here, we have shown a rationale for serology testing as a means to facilitate interventions beyond those of mitigation and suppression. Identifying and deploying recovered individuals could represent more than just a metric of the state of the COVID-19 epidemic, e.g., to better measure prevalence and the 'denominator', but an opportunity to slow transmission by developing population-level shield immunity. Many logistical, social, and dynamical challenges remain if such an idea were to move from theory to feasibility. Accurate and rapid serological tests are needed at scale, including targeted surveys to identify essential workers and via populationlevel surveys. The potential scale of shield immunity depends on both the intrinsic epidemic dynamics, driving the number of recovered individuals able to provide shield immunity, and also on the ability to identify and deploy them (e.g., via the shielding parameter α). Yet, even if such tests were available, who should get them? Public health authorities and governmental agencies should consider how to prioritize those in critical roles, those with experience in disaster response, as well as prior individuals who have tested positive for COVID-19 (and could then return for both serology-based and viral shedding assays). Positive confirmation of immunity and cessation of viral shedding could help identify and deploy (tens of) thousands of individuals as part of a shield immunity strategy, with the greatest concentration likely co-located with areas in greatest need of intervention. A national (or global) strategy could consider the deployment of critical response workers to help control new outbreaks.

    Search related documents:
    Co phrase search for related documents
    • critical role and epidemic dynamic: 1, 2, 3
    • disaster response and essential worker: 1